Questcor Finds Profit for Acthar Drug, at $28,000 a Vial
Saturday, December 29, 2012 - 23:40
in Mathematics & Economics
After pricing its once-obscure drug, Acthar, in the stratosphere, Questcor gained many fans on Wall Street. But the company has also drawn some doubters.